CSE: 2017-0913 - Name and Symbol Change and Consolidation - M Pharmaceutical Inc. (MQ)
(firmenpresse) - TORONTO, ONTARIO -- (Marketwired) -- 09/19/17 -- M Pharmaceutical Inc. has announced a name change to Callitas Health Inc. and a share consolidation of its issued and outstanding common shares on a one (1) post consolidation share for each ten (10) pre-consolidation common shares. No fractional shares will be issued -all fractional shares will be rounded to the nearest whole number.
As a result, the outstanding shares of the company will be reduced to approximately 32,462,095.
The shares will begin trading under the new name and symbol on September 20, 2017.
Please note that all open orders will be cancelled at the end of business on September 19, 2017. Dealers are reminded to re-enter their orders taking into account the share consolidation.
Contacts:
Canadian Securities Exchange (CSE)
Listings
(416) 367-7340
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 19.09.2017 - 13:47 Uhr
Sprache: Deutsch
News-ID 1521291
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
TORONTO, ONTARIO
Phone:
Kategorie:
Investment Services & Trading
Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 595 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"CSE: 2017-0913 - Name and Symbol Change and Consolidation - M Pharmaceutical Inc. (MQ)
"
steht unter der journalistisch-redaktionellen Verantwortung von
Canadian Securities Exchange (CSE) (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
